查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493196

體外診斷品管市場規模、佔有率和趨勢分析報告：按產品類型、按應用、按製造商類型、按最終用途、按地區和細分趨勢：2024-2030

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Manufacturer Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10個工作天內

價格

體外診斷品管市場成長與趨勢：

根據Grand View Research, Inc.最新報告，到2030年，全球體外診斷品管市場規模預計將達到15.9億美元，2024年至2030年複合年成長率為3.2%。

診斷領域不斷發展的以技術為導向的變化以及確保患者安全的日益成長的需求使得必須在多個醫療領域實施品質保證計劃，包括照護現場設備和放射學。由於患者依賴自檢體外診斷 (IVD) 設備進行長期疾病管理，因此確保此類 IVD 設備結果的可重複性和有效性對於確保患者安全至關重要，因此從這一點檢查品質非常重要。

越來越多的經認可的臨床實驗室提供可靠的基於 IVD 的診斷服務，這是市場成長的推動力，因為它直接轉化為患者信心的提高。多重PCR常規診斷的主要病原體包括HIV、HSV（腦膜炎和腦炎）、流感嗜血桿菌、肺炎鏈球菌（呼吸道感染疾病）、淋病奈瑟菌和沙眼衣原體（生殖器感染疾病）、蘭巴迪亞衣原體、沙眼利什曼原蟲症。除了評估之外，還對法規結構進行間歇性修訂，以加強現行標準，主要目的是保障向患者提供的診斷服務的品質卓越。

實驗室的品管重點是確保向患者提供的結果準確。控制測試通常在儀器安裝期間、維護後、試劑批次變更或儀器讀數不在範圍內時進行。居家照護環境包括用於在患者床邊進行測試的各種照護端 (PoC) 設備、檢測套組以及醫療保健支援環境中的體外診斷 (IVD) 設備。自檢檢測套組對於需要常規檢測的患者來說很方便，可以進一步減少就診次數。

體外診斷品管市場報告亮點

  • 2023年，臨床化學領域佔最大市場佔有率。對預防醫學的需求不斷成長以及臨床實驗室迅速轉變為高度自動化和高效的企業是導致高市場佔有率的因素。
  • 品管領域預計將在 2023 年佔據市場主導地位，並在市場估計和預測期內以最高複合年成長率成長。實驗室的品管重點是證明提供給個人的結果是準確的。
  • 由於基於次世代定序(NGS)、質譜、微陣列等先進技術的設備以及最佳化品管程序的應用不斷增加，醫院細分市場將在 2023 年佔據最大佔有率。
  • 許多製藥公司正在實施美國FDA 制定的新指南草案，以確保現行良好生產規範 (cGMP) 的資料完整性。
  • 本指南提供了與建立健全的操作程序和強大的控制系統、獲取高品質原料、調查偏差以及維護可靠的診斷實驗室相關的資訊。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 配套市場前景
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
    • 機會分析
    • 供應鏈分析
  • 營商環境分析
    • PESTEL分析
    • 波特五力分析

第4章體外診斷品管市場：依產品細分分析，2018-2030

  • 體外診斷品管市場：產品變異分析
  • 體外診斷品管市場估計與預測：按產品
  • 控制
  • 校準器
  • 其他

第5章體外診斷品管市場：按類型細分分析，2018-2030

  • 體外診斷品管市場：類型變異分析
  • 體外診斷品管市場估計與預測：按類型
  • 品管
  • 品質保證服務
  • 資料管理解決方案

第6章 體外診斷品管市場：依應用估算與趨勢分析

  • 體外診斷品管市場：應用變異分析
  • 體外診斷品管市場估計與預測：按應用
  • 免疫化學
  • 血液學
  • 臨床化學

第7章體外診斷品管市場：按製造商類型估計和趨勢分析

  • 體外診斷品管市場：製造商類型變異分析
  • 體外診斷品管市場估計和預測：按製造商類型
  • 第三方管理
  • OEM管理

第8章體外診斷品管市場：最終用途估計與趨勢分析

  • 體外診斷品管市場：最終用途變異分析
  • 按最終用途分類的體外診斷品管市場估計和預測
  • 醫院
  • 實驗室
  • 居家照護
  • 其他

第 9 章 體外診斷品管市場：區域估計與趨勢分析，按產品、類型、應用、製造商類型、最終用途

  • 體外診斷品管市場：區域展望
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭格局

  • 公司分類
  • 參與企業概況
  • 財務績效
  • 產品基準
    • 2023 年體外診斷品管市場佔有率分析
    • 2023 年等離子控制設備企業市場佔有率
    • 2023 年以血清為基礎的對照品企業市場佔有率
    • 2023 年全血對照試驗中的企業市場佔有率
  • 策略規劃
    • 併購
    • 夥伴關係與協作
    • 擴張
    • 產品核准和上市
    • 其他

第11章 公司簡介

  • 公司分類
  • 參與企業概況
    • Siemens Healthineers AG
    • Abbott
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • F. Hoffmann-La Roche Ltd
    • Sysmex Corporation
    • QuidelOrtho Corporation
    • Randox Laboratories Ltd
    • Helena Laboratories Corporation
    • Thermo Fisher Scientific, Inc.
    • SeraCare Life Sciences, Inc.
    • BD
    • Merck KGaA
    • QIAGEN
    • Hologic, Inc.
    • Bio-Techne
    • Fortress Diagnostics
    • Microbiologics
    • TRINA BIOREACTIVES AG
    • ConeBioproducts
    • Biorex Diagnostics
  • 財務績效
  • 產品基準
Product Code: 978-1-68038-925-8

In Vitro Diagnostics Quality Control Market Growth & Trends:

The global in vitro diagnostics quality control market size is expected to reach USD 1.59 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the execution of quality assurance programs in several medical domains including point-of-care devices and radiology.The patients rely on self-testing in vitro diagnostics (IVD) devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity to guarantee patient safety.

The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving market growth. Some of the key pathogens routinely diagnosed using multiplex PCR, but not limited to, are HIV, HSV (meningitis and encephalitis), H. influenza, S. pneumonia (respiratory tract infections), N. gonorrhea, C. trachoma (genital infections), G. lambardia, C. parvum (diarrheal diseases), and Leishmaniaspp (Leishmaniasis).In addition to assessments, amendments to the regulatory framework are made intermittently to enhance the present standards with the main objective of safeguarding the qualitative superiority of the diagnostic services rendered to patients.

Quality control in the laboratory is focused on ensuring that the results delivered to the patient are accurate. Control checks are usually undertaken while installing an instrument, after servicing, changing reagent lots, and when the instrument readings are not in range.Home care settings include a variety of devices, such as point-of-care (PoC) instruments used for near-patient bed testing, self-testing kits, and IVD devices in assisted healthcare settings. Self-testing kits giveease of convenience for patients who require everyday testing and further reduce hospital visits.

In Vitro Diagnostics Quality Control Market Report Highlights:

  • In 2023, the clinical chemistry segment held the largest share of the market. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors responsible for its high market share
  • The quality control segment dominated the market in 2023 and is estimated to grow at the highest CAGR over the forecast period. Quality control in the research laboratory is concentrated on certifying the results provided to the individuals are precise
  • The hospital segment held the largest share in 2023 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
  • Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP)
  • It provides information in relation to establishing robust operating procedures and strong management systems, obtaining high-quality raw materials, investigating deviations, and maintaining reliable diagnostic laboratories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Regional scope
    • 1.1.2. Market definitions
    • 1.1.3. Estimates and forecasts timeline
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
      • 1.7.1.2. Approach 2: Country wise market estimation using bottom-up approach.
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. By Product and Type Segment Snapshot
  • 2.3. By application and Manufacturer Type Segment Snapshot
  • 2.4. By End-use Segment Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising number of accredited clinical laboratories
      • 3.2.1.2. Increasing third-party quality control services
      • 3.2.1.3. Presence of favorable regulatory bodies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of IVD quality control services
      • 3.2.2.2. Unfavorable reimbursement scenario in IVD industry
    • 3.2.3. Opportunity analysis
    • 3.2.4. Supply chain analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. PESTEL analysis
    • 3.3.2. Porter's five forces analysis

Chapter 4. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)

  • 4.1. In Vitro Diagnostics Quality Control Market: Product movement Analysis
  • 4.2. In Vitro Diagnostics Quality Control Market Estimates & Forecast, by Product (USD Million)
    • 4.2.1. Controls
      • 4.2.1.1. Total protein
      • 4.2.1.2. Albumin
      • 4.2.1.3. Blood urea nitrogen
      • 4.2.1.4. Uric acid
      • 4.2.1.5. Creatinine
      • 4.2.1.6. Sodium
      • 4.2.1.7. Potassium
      • 4.2.1.8. Chloride
      • 4.2.1.9. Calcium
      • 4.2.1.10. Magnesium
      • 4.2.1.11. Inorganic phosphorus
      • 4.2.1.12. Aspartate transaminase
      • 4.2.1.13. Creatine kinase
      • 4.2.1.14. Gamma glutamyl transferase
      • 4.2.1.15. Total bilirubin
      • 4.2.1.16. C-Reactive Protein
      • 4.2.1.17. Glucose
      • 4.2.1.18. Iron
      • 4.2.1.19. Alanine transaminase
      • 4.2.1.20. Alkaline phosphatase
      • 4.2.1.21. Alpha-amylase
      • 4.2.1.22. Total cholesterol
      • 4.2.1.23. Triglyceride
      • 4.2.1.24. Lactate dehydrogenase
      • 4.2.1.25. Immunoglobulin G
      • 4.2.1.26. Immunoglobulin A
      • 4.2.1.27. Immunoglobulin M
      • 4.2.1.28. Complement 3
      • 4.2.1.29. Complement 4
      • 4.2.1.30. Rheumatoid factor
      • 4.2.1.31. Anti-Streptolysin -O
      • 4.2.1.32. Beta 2 microglobulin
      • 4.2.1.33. Cystatin-C
      • 4.2.1.34. Myoglobin
      • 4.2.1.35. Troponin T and I
      • 4.2.1.36. Others
    • 4.2.2. Calibrators
    • 4.2.3. Others

Chapter 5. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1. In Vitro Diagnostics Quality Control Market: Type Movement Analysis
  • 5.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Type (USD Million)
    • 5.2.1. Quality Controls
      • 5.2.1.1. Plasma-based control
      • 5.2.1.2. Serum-based control
      • 5.2.1.3. Whole blood-based Control
      • 5.2.1.4. Others
    • 5.2.2. Quality Assurance Services
    • 5.2.3. Data Management Solutions

Chapter 6. In Vitro Diagnostics Quality Control Market: By Application Estimates & Trend Analysis

  • 6.1. In Vitro Diagnostics Quality Control Market: Application Movement Analysis
  • 6.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Application (USD Million)
  • 6.3. Immunochemistry
  • 6.4. Hematology
  • 6.5. Clinical Chemistry
      • 6.5.1.1. Alkaline Phosphatase (ALP)
      • 6.5.1.2. Alanine Transaminase (ALT)
      • 6.5.1.3. Aspartate Transaminase (AST)
      • 6.5.1.4. Creatine Kinase MB (CK-MB)
      • 6.5.1.5. Albumin
      • 6.5.1.6. Creatinine
      • 6.5.1.7. Glucose
      • 6.5.1.8. Triglycerides
      • 6.5.1.9. Amylase
      • 6.5.1.10. Others
    • 6.5.2. Molecular diagnostics
    • 6.5.3. Coagulation
    • 6.5.4. Microbiology
    • 6.5.5. Others

Chapter 7. In Vitro Diagnostics Quality Control Market: By Manufacturer Type Estimates & Trend Analysis

  • 7.1. In Vitro Diagnostics Quality Control Market: Manufacturer Type Movement Analysis
  • 7.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Manufacturer Type (USD Million)
    • 7.2.1. Third-party controls
      • 7.2.1.1. Independent controls
      • 7.2.1.2. Instrument specific controls
    • 7.2.2. OEM controls

Chapter 8. In Vitro Diagnostics Quality Control Market: End-use Estimates & Trend Analysis

  • 8.1. In Vitro Diagnostics Quality Control Market: End-use Movement Analysis
  • 8.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by End-use (USD Million)
    • 8.2.1. Hospitals
    • 8.2.2. Laboratories
    • 8.2.3. Home care
    • 8.2.4. Others

Chapter 9. In Vitro Diagnostics Quality Control Market: Regional Estimates & Trend Analysis, by Product, Type, Application, Manufacturer Type, and End-use

  • 9.1. In Vitro Diagnostics Quality Control Market: Regional Outlook
  • 9.2. North America
    • 9.2.1. North America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.2.2. U.S.
      • 9.2.2.1. Key country dynamics
      • 9.2.2.2. U.S. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.2.2.3. Competitive/ market scenario
      • 9.2.2.4. Regulatory framework
    • 9.2.3. Canada
      • 9.2.3.1. Key country dynamics
      • 9.2.3.2. Canada in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.2.3.3. Competitive/ market scenario
      • 9.2.3.4. Regulatory framework
  • 9.3. Europe
    • 9.3.1. Europe in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.3.2. UK
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. UK in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.2.3. Competitive/ market scenario
      • 9.3.2.4. Regulatory framework
    • 9.3.3. Germany
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Germany in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.3.3. Competitive/ market scenario
      • 9.3.3.4. Regulatory framework
    • 9.3.4. France
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. France in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.4.3. Competitive/ market scenario
      • 9.3.4.4. Regulatory framework
    • 9.3.5. Italy
      • 9.3.5.1. Key country dynamics
      • 9.3.5.2. Italy in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.5.3. Competitive/ market scenario
      • 9.3.5.4. Regulatory framework
    • 9.3.6. Spain
      • 9.3.6.1. Key country dynamics
      • 9.3.6.2. Spain in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.6.3. Competitive/ market scenario
      • 9.3.6.4. Regulatory framework
    • 9.3.7. Denmark
      • 9.3.7.1. Key country dynamics
      • 9.3.7.2. Denmark in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.7.3. Competitive/ market scenario
      • 9.3.7.4. Regulatory framework
    • 9.3.8. Sweden
      • 9.3.8.1. Key country dynamics
      • 9.3.8.2. Sweden in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.8.3. Competitive/ market scenario
      • 9.3.8.4. Regulatory framework
    • 9.3.9. Norway
      • 9.3.9.1. Key country dynamics
      • 9.3.9.2. Norway in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.3.9.3. Competitive/ market scenario
      • 9.3.9.4. Regulatory framework
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.4.2. Japan
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Japan in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.2.3. Competitive/ market scenario
      • 9.4.2.4. Regulatory framework
    • 9.4.3. China
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. China in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.3.3. Competitive/ market scenario
      • 9.4.3.4. Regulatory framework
    • 9.4.4. India
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. India in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.4.3. Competitive/ market scenario
      • 9.4.4.4. Regulatory framework
    • 9.4.5. Australia
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Australia in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.5.3. Competitive/ market scenario
      • 9.4.5.4. Regulatory framework
    • 9.4.6. Thailand
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Thailand in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.6.3. Competitive/ market scenario
      • 9.4.6.4. Regulatory framework
    • 9.4.7. South Korea
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. South Korea in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.4.7.3. Competitive/ market scenario
      • 9.4.7.4. Regulatory framework
  • 9.5. Latin America
    • 9.5.1. Latin America in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.5.2. Brazil
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Brazil in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.2.3. Competitive/ market scenario
      • 9.5.2.4. Regulatory framework
    • 9.5.3. Mexico
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Mexico in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.3.3. Competitive/ market scenario
      • 9.5.3.4. Regulatory framework
    • 9.5.4. Argentina
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Argentina in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.5.4.3. Competitive/ market scenario
      • 9.5.4.4. Regulatory framework
  • 9.6. MEA
    • 9.6.1. MEA in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
    • 9.6.2. South Africa
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. South Africa in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.2.3. Competitive/ market scenario
      • 9.6.2.4. Regulatory framework
    • 9.6.3. Saudi Arabia
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Saudi Arabia. in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.3.3. Competitive/ market scenario
      • 9.6.3.4. Regulatory framework
    • 9.6.4. UAE
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. UAE in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.4.3. Competitive/ market scenario
      • 9.6.4.4. Regulatory framework
    • 9.6.5. Kuwait
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Kuwait in vitro diagnostics quality control market estimates and forecasts, 2018 - 2030 (USD Million)
      • 9.6.5.3. Competitive/ market scenario
      • 9.6.5.4. Regulatory framework

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Participant's Overview
  • 10.3. Financial Performance
  • 10.4. Product Benchmarking
    • 10.4.1. In vitro diagnostics quality control market share analysis, 2023
    • 10.4.2. Company market share, 2023 for plasma-based controls
    • 10.4.3. Company market share, 2023 for serum-based controls
    • 10.4.4. Company market share, 2023 for whole blood-based controls
  • 10.5. Strategy Mapping
    • 10.5.1. Mergers & acquisitions
    • 10.5.2. Partnerships & collaborations
    • 10.5.3. Expansion
    • 10.5.4. Product approval & launch
    • 10.5.5. Others

Chapter 11. Company Profiles

  • 11.1. Company Categorization
  • 11.2. Participant's Overview
    • 11.2.1. Siemens Healthineers AG
    • 11.2.2. Abbott
    • 11.2.3. Bio-Rad Laboratories, Inc.
    • 11.2.4. Danaher
    • 11.2.5. F. Hoffmann-La Roche Ltd
    • 11.2.6. Sysmex Corporation
    • 11.2.7. QuidelOrtho Corporation
    • 11.2.8. Randox Laboratories Ltd
    • 11.2.9. Helena Laboratories Corporation
    • 11.2.10. Thermo Fisher Scientific, Inc.
    • 11.2.11. SeraCare Life Sciences, Inc.
    • 11.2.12. BD
    • 11.2.13. Merck KGaA
    • 11.2.14. QIAGEN
    • 11.2.15. Hologic, Inc.
    • 11.2.16. Bio-Techne
    • 11.2.17. Fortress Diagnostics
    • 11.2.18. Microbiologics
    • 11.2.19. TRINA BIOREACTIVES AG
    • 11.2.20. ConeBioproducts
    • 11.2.21. Biorex Diagnostics
  • 11.3. Financial Performance
  • 11.4. Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 In vitro diagnostics quality control market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
  • Table 4 In vitro diagnostics quality control market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
  • Table 5 In vitro diagnostics quality control market revenue estimates and forecast, by application, 2018 - 2030 (USD Million)
  • Table 6 In vitro diagnostics quality control market revenue estimates and forecast, by manufacturer type, 2018 - 2030 (USD Million)
  • Table 7 In vitro diagnostics quality control market revenue estimates and forecast, by end-use, 2018 - 2030 (USD Million)
  • Table 8 The classification of levels of IVD in South Africa
  • Table 9 Company market share, 2023

List of Figures

  • Fig. 1 In vitro diagnostics quality control market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Product and type segment snapshot
  • Fig. 11 Application and manufacturer type segment snapshot
  • Fig. 12 End-use segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 In vitro diagnostics market value, 2023 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 In vitro diagnostics quality control market: Product outlook and key takeaways
  • Fig. 19 In vitro diagnostics quality control market: Product movement analysis
  • Fig. 20 Controls market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Controls market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 22 Total protein estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Total protein market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 24 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 26 Blood urea nitrogen estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Blood urea market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 28 Uric acid market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Uric acid market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 30 Creatinine estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 32 Sodium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Sodium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 34 Potassium estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Potassium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 36 Chloride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Chloride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 38 Calcium estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Calcium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 40 Magnesium market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 magnesium market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 42 Inorganic phosphorus estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Inorganic phosphorous market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 44 Aspartate transaminase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Aspartate transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 46 Creatine kinase estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Creatine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 48 Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Gamma glutamyl market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 50 Total bilirubin estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Total bilirubin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 52 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 54 C-reactive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 C-reactive market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 56 Iron market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Iron market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 58 Alanine transaminase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Alanine transaminase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 60 Alkaline phosphatase estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Alkaline phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 62 Alpha amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Alpha amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 64 Total cholesterol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Total cholesterol market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 66 Triglyceride estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Triglyceride market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 68 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 70 Immunoglobulin G estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Immunoglobulin G market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 72 Immunoglobulin A market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Immunoglobulin A market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 74 Immunoglobulin M market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Immunoglobulin M market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 76 Complement 3market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Complement 3 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 78 Complement 4 estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Complement 4 market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 80 Rheumatoid factor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Rheumatoid factor market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 82 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Anti-streptolysin -O market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 84 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Beta 2 microglobulin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 86 Cystatin-C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Cystatin-C market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 88 Myoglobin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Myoglobin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 90 Troponin T and I market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Troponin T and I market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 92 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 94 Calibrators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Calibrators market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 96 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 98 In vitro diagnostics quality control market: type movement analysis
  • Fig. 99 In vitro diagnostics quality control market: type outlook and key takeaways
  • Fig. 100 Quality controls market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Quality controls assurance services estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Plasma-based control market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Plasma-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 104 Serum-based control estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Serum-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 106 Whole blood-based control market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Whole blood-based control market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 108 Others estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Others estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 110 Quality assurance services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Data management solutions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 In vitro diagnostics quality control market: Application movement analysis
  • Fig. 113 In vitro diagnostics quality control market: Application outlook and key takeaways
  • Fig. 114 Immunochemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Immunochemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 116 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Hematology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 118 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 119 Clinical chemistry market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 120 Alkaline phosphatase (ALP) Molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 Alkaline phosphatase (ALP) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 122 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Alanine transaminase (ALT) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 124 Aspartate transaminase (AST) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Aspartate transaminase (AST) phosphatase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 126 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Creatine kinase MB (CK-MB) market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 128 Albumin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Albumin market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 130 Creatinine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Creatinine market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 132 Glucose market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Glucose market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 134 Triglycerides market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Triglycerides market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 136 Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Amylase market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 138 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 140 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Molecular diagnostics market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 142 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Coagulation market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 144 Microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 Microbiology market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 146 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 147 Others market estimates and forecast, 2018 - 2030 (Number of Units, thousands)
  • Fig. 148 In vitro diagnostics quality control market: Manufacturer type movement Analysis
  • Fig. 149 In vitro diagnostics quality control market: Manufacturer type outlook and key takeaways
  • Fig. 150 Third-party controls market estimates and forecasts, 2018 - 2030
  • Fig. 151 Independent controls market estimates and forecasts, 2018 - 2030
  • Fig. 152 Instrument specific controls market estimates and forecasts,2018 - 2030
  • Fig. 153 OEM controls market estimates and forecasts,2018 - 2030
  • Fig. 154 In vitro diagnostics quality control market: End-use movement Analysis
  • Fig. 155 In vitro diagnostics quality control market: End-use outlook and key takeaways
  • Fig. 156 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 157 Laboratories market estimates and forecasts,2018 - 2030
  • Fig. 158 Home Care market estimates and forecasts, 2018 - 2030
  • Fig. 159 Others market estimates and forecasts,2018 - 2030
  • Fig. 160 In-vitro diagnostics quality control market revenue, by region, 2023 & 2030 (USD Million)
  • Fig. 161 Regional marketplace: key takeaways
  • Fig. 162 Regional marketplace: key takeaways
  • Fig. 163 North America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Key country dynamics
  • Fig. 165 U.S. in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Key country dynamics
  • Fig. 167 Canada in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 169 Key country dynamics
  • Fig. 170 UK in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 171 Key country dynamics
  • Fig. 172 Germany in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 173 Key country dynamics
  • Fig. 174 France in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 175 Key country dynamics
  • Fig. 176 Italy in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 177 Key country dynamics
  • Fig. 178 Spain in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 179 Key country dynamics
  • Fig. 180 Denmark in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 181 Key country dynamics
  • Fig. 182 Sweden in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 183 Key country dynamics
  • Fig. 184 Norway in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 185 Rest of Europe in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 186 Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 187 Key country dynamics
  • Fig. 188 Japan in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 189 Key country dynamics
  • Fig. 190 China in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 191 Key country dynamics
  • Fig. 192 India in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 193 Key country dynamics
  • Fig. 194 Australia vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 195 Key country dynamics
  • Fig. 196 Thailand in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 197 Key country dynamics
  • Fig. 198 South Korea in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 199 Rest of Asia Pacific in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 200 Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 201 Key country dynamics
  • Fig. 202 Brazil in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 203 Key country dynamics
  • Fig. 204 Mexico in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 205 Key country dynamics
  • Fig. 206 Argentina in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 207 Rest of Latin America in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 208 MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 209 Key country dynamics
  • Fig. 210 South Africa in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 211 Key country dynamics
  • Fig. 212 Saudi Arabia in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 213 Key country dynamics
  • Fig. 214 UAE in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 215 Key country dynamics
  • Fig. 216 Kuwait in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 217 Rest of MEA in vitro diagnostics quality control market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 218 Key company categorization
  • Fig. 219 In vitro diagnostics quality control market share analysis, 2023
  • Fig. 220 Company market share, 2023 for plasma-based controls
  • Fig. 221 Company market share, 2023 for serum-based controls
  • Fig. 222 Company market share, 2023 for whole blood-based controls
  • Fig. 223 Strategy mapping